Unión Europea -
noruego -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Unión Europea -
noruego -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Unión Europea -
noruego -
EMA (European Medicines Agency)
tadalafil mylan
mylan pharmaceuticals limited - tadalafil - erektil dysfunksjon - urologika - behandling av erektil dysfunksjon hos voksne hanner. for at tadalafil skal være effektiv, kreves seksuell stimulering. tadalafil mylan er ikke indisert for bruk av kvinner.
Noruega -
noruego -
Statens legemiddelverk
tadalafil cipla 20 mg
cipla europe nv - tadalafil - tablett, filmdrasjert - 20 mg
Noruega -
noruego -
Statens legemiddelverk
tadalafil cipla 2.5 mg
cipla europe nv - tadalafil - tablett, filmdrasjert - 2.5 mg
Noruega -
noruego -
Statens legemiddelverk
tadalafil cipla 5 mg
cipla europe nv - tadalafil - tablett, filmdrasjert - 5 mg
Noruega -
noruego -
Statens legemiddelverk
tadalafil cipla 10 mg
cipla europe nv - tadalafil - tablett, filmdrasjert - 10 mg
Noruega -
noruego -
Statens legemiddelverk
tadalafil aop 20 mg
aop orphan pharmaceuticals gmbh - tadalafil - tablett, filmdrasjert - 20 mg
Unión Europea -
noruego -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulær blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Unión Europea -
noruego -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.